Upregulated piR-52207 targets NUDT4, MTR, EIF2S3, and MPHOSPH8, which promote endometrioid ovarian cancer cell proliferation, migration, and tumorigenesis. This evidence concerns the gene PIR and ovarian endometrioid adenocarcinoma.